Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1986 Dec;83(23):9197–9201. doi: 10.1073/pnas.83.23.9197

Activation of phospholipases A and C in human platelets exposed to epinephrine: role of glycoproteins IIb/IIIa and dual role of epinephrine.

H S Banga, E R Simons, L F Brass, S E Rittenhouse
PMCID: PMC387102  PMID: 3024170

Abstract

Human platelets stimulated by epinephrine undergo enhanced turnover of phosphatidylinositol 4,5-bisphosphate, accumulate inositol trisphosphate, diacylglycerol, and phosphatidic acid, and phosphorylate a 47-kDa protein. All of these phenomena indicate stimulation of phospholipase C. These responses are blocked completely by inhibitors of alpha 2-adrenergic receptors (yohimbine), cyclooxygenase (aspirin or indomethacin), phospholipase A [2-(p-amylcinnamoyl)amino-4-chlorobenzoic acid (ONO-RS-082)], Na+/H+ exchange [ethylisopropylamiloride (EIPA)], fibrinogen binding to glycoprotein IIb/IIIa (antibody A2A9), Ca2+/Mg+ binding (EDTA), or removal of fibrinogen. Epinephrine evokes (i) an increased turnover of ester-linked arachidonic acid in aspirin treated platelets that is inhibited by ONO-RS-082, EDTA, yohimbine, or the absence of fibrinogen and (ii) a rapid cytoplasmic alkalinization that is inhibited partially by blockage of cyclooxygenase activity and completely by A2A9 or EIPA. In contrast, when incubated with subaggregatory concentrations of the prostaglandin H2/thromboxane A2 analogue [(15S)-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid (U46619) and epinephrine, aspirin-treated platelets show a potentiation of phospholipase C activation that is unaffected by the above inhibitors. We propose that epinephrine, in promoting exposure of glycoprotein IIb/IIIa sites for fibrinogen binding, leads to a cytoplasmic alkalinization, which, in conjunction with local shifts in Ca2+, promotes low-level activation of phospholipase A. The resulting free arachidonic acid is converted to cyclooxygenase products, which, potentiated by epinephrine, activate phospholipase C. This further amplifies the initial stimulatory response.

Full text

PDF
9197

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bennett J. S., Hoxie J. A., Leitman S. F., Vilaire G., Cines D. B. Inhibition of fibrinogen binding to stimulated human platelets by a monoclonal antibody. Proc Natl Acad Sci U S A. 1983 May;80(9):2417–2421. doi: 10.1073/pnas.80.9.2417. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bennett J. S., Vilaire G., Cines D. B. Identification of the fibrinogen receptor on human platelets by photoaffinity labeling. J Biol Chem. 1982 Jul 25;257(14):8049–8054. [PubMed] [Google Scholar]
  3. Bennett J. S., Vilaire G. Exposure of platelet fibrinogen receptors by ADP and epinephrine. J Clin Invest. 1979 Nov;64(5):1393–1401. doi: 10.1172/JCI109597. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Block L. H., Jaksche H., Erne P., Bolli P., Bühler F. R. (-)-Adrenaline-induced, calcium-dependent phosphorylation of proteins in human platelets. J Clin Invest. 1985 May;75(5):1600–1607. doi: 10.1172/JCI111866. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Brass L. F., Shattil S. J., Kunicki T. J., Bennett J. S. Effect of calcium on the stability of the platelet membrane glycoprotein IIb-IIIa complex. J Biol Chem. 1985 Jul 5;260(13):7875–7881. [PubMed] [Google Scholar]
  6. Deykin D., Snyder D. Effect of epinephrine on platelet lipid metabolism. J Lab Clin Med. 1973 Oct;82(4):554–559. [PubMed] [Google Scholar]
  7. Fain J. N., García-Sáinz J. A. Role of phosphatidylinositol turnover in alpha 1 and of adenylate cyclase inhibition in alpha 2 effects of catecholamines. Life Sci. 1980 Apr 14;26(15):1183–1194. doi: 10.1016/0024-3205(80)90062-4. [DOI] [PubMed] [Google Scholar]
  8. Figures W. R., Scearce L. M., Wachtfogel Y., Chen J., Colman R. F., Colman R. W. Platelet ADP receptor and alpha 2-adrenoreceptor interaction. Evidence for an ADP requirement for epinephrine-induced platelet activation and an influence of epinephrine on ADP binding. J Biol Chem. 1986 May 5;261(13):5981–5986. [PubMed] [Google Scholar]
  9. Grant J. A., Scrutton M. C. Novel alpha2-adrenoreceptors primarily responsible for inducing human platelet aggregation. Nature. 1979 Feb 22;277(5698):659–661. doi: 10.1038/277659a0. [DOI] [PubMed] [Google Scholar]
  10. Grant J. A., Scrutton M. C. Positive interaction between agonists in the aggregation response of human blood platelets: interation between ADP, adrenaline and vasopressin. Br J Haematol. 1980 Jan;44(1):109–125. doi: 10.1111/j.1365-2141.1980.tb01189.x. [DOI] [PubMed] [Google Scholar]
  11. Hoffman B. B., De Lean A., Wood C. L., Schocken D. D., Lefkowitz R. J. Alpha-adrenergic receptor subtypes: quantitative assessment by ligand binding. Life Sci. 1979 May 7;24(19):1739–1745. doi: 10.1016/0024-3205(79)90061-4. [DOI] [PubMed] [Google Scholar]
  12. Horne W. C., Norman N. E., Schwartz D. B., Simons E. R. Changes in cytoplasmic pH and in membrane potential in thrombin-stimulated human platelets. Eur J Biochem. 1981 Nov;120(2):295–302. doi: 10.1111/j.1432-1033.1981.tb05703.x. [DOI] [PubMed] [Google Scholar]
  13. Moolenaar W. H., Tertoolen L. G., de Laat S. W. Phorbol ester and diacylglycerol mimic growth factors in raising cytoplasmic pH. Nature. 1984 Nov 22;312(5992):371–374. doi: 10.1038/312371a0. [DOI] [PubMed] [Google Scholar]
  14. Rittenhouse-Simmons S., Russell F. A., Deykin D. Mobilization of arachidonic acid in human platelets. Kinetics and Ca2+ dependency. Biochim Biophys Acta. 1977 Sep 28;488(3):370–380. doi: 10.1016/0005-2760(77)90196-5. [DOI] [PubMed] [Google Scholar]
  15. Rittenhouse S. E. Activation of human platelet phospholipase C by ionophore A23187 is totally dependent upon cyclo-oxygenase products and ADP. Biochem J. 1984 Aug 15;222(1):103–110. doi: 10.1042/bj2220103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Rittenhouse S. E., Horne W. C. Ionomycin can elevate intraplatelet Ca2+ and activate phospholipase A without activating phospholipase C. Biochem Biophys Res Commun. 1984 Aug 30;123(1):393–397. doi: 10.1016/0006-291x(84)90426-1. [DOI] [PubMed] [Google Scholar]
  17. Rittenhouse S. E. Human platelets contain phospholipase C that hydrolyzes polyphosphoinositides. Proc Natl Acad Sci U S A. 1983 Sep;80(17):5417–5420. doi: 10.1073/pnas.80.17.5417. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Rittenhouse S. E., Sasson J. P. Mass changes in myoinositol trisphosphate in human platelets stimulated by thrombin. Inhibitory effects of phorbol ester. J Biol Chem. 1985 Jul 25;260(15):8657–8660. [PubMed] [Google Scholar]
  19. Russell F. A., Deykin D. The use of high pressure liquid chromatography (HPLC) for the separation of radiolabeled arachidonic acid and its metabolities produced by thrombin-treated human platelets. I. The validation of the technique. Prostaglandins. 1979 Jul;18(1):11–18. doi: 10.1016/s0090-6980(79)80018-0. [DOI] [PubMed] [Google Scholar]
  20. Siess W., Weber P. C., Lapetina E. G. Activation of phospholipase C is dissociated from arachidonate metabolism during platelet shape change induced by thrombin or platelet-activating factor. Epinephrine does not induce phospholipase C activation or platelet shape change. J Biol Chem. 1984 Jul 10;259(13):8286–8292. [PubMed] [Google Scholar]
  21. Sun F. F., McGuire J. C., Metzler C. M. The effect of substrate availability on the metabolism of arachidonic acid in human platelets. Prog Lipid Res. 1981;20:275–278. doi: 10.1016/0163-7827(81)90054-0. [DOI] [PubMed] [Google Scholar]
  22. Sweatt J. D., Johnson S. L., Cragoe E. J., Limbird L. E. Inhibitors of Na+/H+ exchange block stimulus-provoked arachidonic acid release in human platelets. Selective effects on platelet activation by epinephrine, ADP, and lower concentrations of thrombin. J Biol Chem. 1985 Oct 25;260(24):12910–12919. [PubMed] [Google Scholar]
  23. Wallace M. A., Agarwal K. C., Garcia-Sainz J. A., Fain J. N. Alpha-adrenergic stimulation of phosphatidylinositol synthesis in human platelets as an alpha-2 effect secondary to platelet aggregation. J Cell Biochem. 1982;18(2):213–220. doi: 10.1002/jcb.1982.240180208. [DOI] [PubMed] [Google Scholar]
  24. Ware J. A., Johnson P. C., Smith M., Salzman E. W. Effect of common agonists on cytoplasmic ionized calcium concentration in platelets. Measurement with 2-methyl-6-methoxy 8-nitroquinoline (quin2) and aequorin. J Clin Invest. 1986 Mar;77(3):878–886. doi: 10.1172/JCI112385. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES